1. Home
  2. FFC vs ABCL Comparison

FFC vs ABCL Comparison

Compare FFC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFC
  • ABCL
  • Stock Information
  • Founded
  • FFC 1983
  • ABCL 2012
  • Country
  • FFC United States
  • ABCL Canada
  • Employees
  • FFC N/A
  • ABCL N/A
  • Industry
  • FFC Trusts Except Educational Religious and Charitable
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFC Finance
  • ABCL Health Care
  • Exchange
  • FFC Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • FFC 758.3M
  • ABCL 841.8M
  • IPO Year
  • FFC N/A
  • ABCL 2020
  • Fundamental
  • Price
  • FFC $15.72
  • ABCL $2.85
  • Analyst Decision
  • FFC
  • ABCL Buy
  • Analyst Count
  • FFC 0
  • ABCL 3
  • Target Price
  • FFC N/A
  • ABCL $8.50
  • AVG Volume (30 Days)
  • FFC 164.1K
  • ABCL 2.6M
  • Earning Date
  • FFC 01-01-0001
  • ABCL 02-18-2025
  • Dividend Yield
  • FFC 6.79%
  • ABCL N/A
  • EPS Growth
  • FFC N/A
  • ABCL N/A
  • EPS
  • FFC N/A
  • ABCL N/A
  • Revenue
  • FFC N/A
  • ABCL $32,962,000.00
  • Revenue This Year
  • FFC N/A
  • ABCL N/A
  • Revenue Next Year
  • FFC N/A
  • ABCL $36.56
  • P/E Ratio
  • FFC N/A
  • ABCL N/A
  • Revenue Growth
  • FFC N/A
  • ABCL N/A
  • 52 Week Low
  • FFC $11.90
  • ABCL $2.34
  • 52 Week High
  • FFC $14.96
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • FFC 44.70
  • ABCL 50.52
  • Support Level
  • FFC $15.52
  • ABCL $2.62
  • Resistance Level
  • FFC $16.03
  • ABCL $3.05
  • Average True Range (ATR)
  • FFC 0.15
  • ABCL 0.17
  • MACD
  • FFC -0.02
  • ABCL -0.02
  • Stochastic Oscillator
  • FFC 33.90
  • ABCL 49.46

About FFC Flaherty & Crumrine Preferred and Income Securities Fund Incorporated

Flaherty & Crumrine Preferred and Income Securities Fund Incorporated is a diversified, closed-end management investment company. The fund's investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. It invests in a diversified portfolio of preferred securities.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: